New EndoBarrier tech looks set to rival traditional gastric bypass surgery
A number of patients with type 2 diabetes in the UK have undergone a trial with a new technology to support weight loss and improve ongoing diabetes management.
The NHS treatment has seen a drop in patients’ blood pressure, weight loss by over two stone, and a reduction in insulin intake to approximately 30 units per day.
The EndoBarrier is a plastic sleeve, inserted through the patient’s mouth and placed into the first 60cm of the small intestine.
The elimination of invasive surgery, used through traditional weight loss methods such as gastric bypass surgery, will make the EndoBarrier an increasingly attractive option for diabetic patients, and has seen a regulation in blood sugar levels within its patients, according to the new study.
- Fitbit partners with DexCom, leading shares to rocket
- Obesity figures are rising in Canada
- Singapore's bid to tackle the impacts of sugar hits the drinks industry
A temporary procedure, the Endobarrier is removed after a year and has been fitted in over 50 patients. So far, the majority of patients who have had the technology removed have seen a continual increase in fitness, with weight remaining at a healthy level.
“This first NHS EndoBarrier service demonstrates that EndoBarrier therapy is highly effective in patients with obesity and diabetes that has been very hard to treat, with high patient satisfaction levels, and an acceptable safety profile,” explained the research team.
“The EndoBarrier service could be a safe and cost-effective treatment for the NHS – it does not involve surgery and patients do not have to stay in hospital, so reducing the risk of infection.
On the rise: Doktor.se
1. Doktor.se launches as a digital healthcare platform in Sweden in 2016. The company's focus is on the B2B market, with a mission to help members find, book and get access to healthcare services through telehealth and telephone calls.
2. The company offers healthcare services through its app as well as at bricks and mortar clinics. After raising more than €40 million in a funding round in May 2020 to expand its operations both nationally and overseas, CEO and founder Martin Lindman says there are plans to enter new markets at the beginning of 2021.
3. Belgium becomes the fifth market where Doktor.se provides telemedicine, through Belgium's communications company Proximus Group. It becomes the second most downloaded doctor app in Europe, and over 1.2 million patient consultations are carried out, either through the app or at physical clinics in Sweden. Throughout 2020 it administers over 250,000 COVID-19 antibody tests in Sweden.
4. Doktor.se is the most popular digital healthcare in Sweden, used by approximately one-tenth of the country's population. New funds are raised to offer improved services for mental health and chronic illnesses, and to expand digital services and acquire physical services to integrate into its digital platforms with the aim of creating a hybrid model.
5. The company announces €29.5 million in funding from Chinese technology multinational Tencent Holdings. Doktor.se say the funds will be used to make its global healthcare services more efficient, accessible and affordable.
The platform now employs nurses, doctors and specialist doctors, psychologists, and physiotherapists, and is available across Europe and in Brazil.
6. Over 1.5 million people are currently using healthcare apps developed by Doktor.se, either run by the company or through its SaaS licensing business. There are around 900 people employed by the company, and Doktor.se say that the productivity of medical staff using the platform is up to four times greater than those working in traditional services.